Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy

Background: Diabetic retinopathy (DR), a leading cause of blindness among working-age adults, lacks targeted therapies besides glucose management. Early retinal lesions are linked to serum metabolites, but the underlying peripheral regulatory networks is unclear. Methods: We first established a stre...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaonan Zhang, Yan Liu, Mengxue Xia, Manwen Yang, Yingjie Wu, Fang Zhang
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580825002699
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226947556540416
author Xiaonan Zhang
Yan Liu
Mengxue Xia
Manwen Yang
Yingjie Wu
Fang Zhang
author_facet Xiaonan Zhang
Yan Liu
Mengxue Xia
Manwen Yang
Yingjie Wu
Fang Zhang
author_sort Xiaonan Zhang
collection DOAJ
description Background: Diabetic retinopathy (DR), a leading cause of blindness among working-age adults, lacks targeted therapies besides glucose management. Early retinal lesions are linked to serum metabolites, but the underlying peripheral regulatory networks is unclear. Methods: We first established a streptozotocin (STZ)-induced mouse model of early DR exhibiting retinal inflammation characteristics. This study employed an integrative approach, combining retinal and serum transcriptomic and metabolomic profiles with genome-wide association study (GWAS) data, to identify peripheral metabolites potentially linking early retinal lesions. Results: STZ-induced mice exhibited retinal inflammation and metabolic dysregulation. Metabolites including glucose, sorbitol, and mannitol were altered in both serum and retina, implicating their potential involvement in retinal inflammation. Utilizing GWAS data of diabetic patients, we further explore the potential the upstream regulation of shared metabolites and their peripheral pathways potentially instigating early retinal inflammation through metabolite-related genes correlated with single nucleotide polymorphisms. Key enzyme genes including HK1, HKDC1, AKR1B1 in hyperglycemic pathway, CEL and HMGCR in cholesterol pathway, and ACSL1, PPT2 in palmitic acid pathway, may connect the metabolic network of hyperglycemia, hyperfructosemia and disrupted lipid metabolism to retinopathy. Conclusion: This study elucidates the upstream regulatory network of peripheral serum metabolites associated with early retinal lesions. Specifically, the SNPs in key peripheral enzyme genes may exert remote effects on retinal inflammation in DR. This finding provides insights into the systemic metabolic management and offering peripheral precise early detection and treatment.
format Article
id doaj-art-90fd6866c955464f89096ae4d64ad465
institution Kabale University
issn 2405-5808
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj-art-90fd6866c955464f89096ae4d64ad4652025-08-24T05:13:28ZengElsevierBiochemistry and Biophysics Reports2405-58082025-09-014310218210.1016/j.bbrep.2025.102182Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathyXiaonan Zhang0Yan Liu1Mengxue Xia2Manwen Yang3Yingjie Wu4Fang Zhang5National Clinical Research Center for Eye disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Liaoning Provence Key Laboratory of Genome Engineered Animal Models, National Center of Genetically Engineered Animal Models for International Research, Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian 116000, China; Eye Institute of Shanghai Jiao Tong University School, Shanghai 200080, ChinaNational Clinical Research Center for Eye disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Liaoning Provence Key Laboratory of Genome Engineered Animal Models, National Center of Genetically Engineered Animal Models for International Research, Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian 116000, China; Eye Institute of Shanghai Jiao Tong University School, Shanghai 200080, ChinaNational Clinical Research Center for Eye disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Eye Institute of Shanghai Jiao Tong University School, Shanghai 200080, China; Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai 200080, ChinaNational Clinical Research Center for Eye disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Eye Institute of Shanghai Jiao Tong University School, Shanghai 200080, China; Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai 200080, ChinaLiaoning Provence Key Laboratory of Genome Engineered Animal Models, National Center of Genetically Engineered Animal Models for International Research, Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian 116000, China; Shandong Provincial Hospital, School of Laboratory Animal & Shandong Laboratory Animal Center, Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250021, China; Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY 10010, USA; Corresponding author.Liaoning Provence Key Laboratory of Genome Engineered Animal Models, National Center of Genetically Engineered Animal Models for International Research, Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian 116000, China.National Clinical Research Center for Eye disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; Eye Institute of Shanghai Jiao Tong University School, Shanghai 200080, China; Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai 200080, China; Corresponding author.National Clinical Research Center for Eye disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.Background: Diabetic retinopathy (DR), a leading cause of blindness among working-age adults, lacks targeted therapies besides glucose management. Early retinal lesions are linked to serum metabolites, but the underlying peripheral regulatory networks is unclear. Methods: We first established a streptozotocin (STZ)-induced mouse model of early DR exhibiting retinal inflammation characteristics. This study employed an integrative approach, combining retinal and serum transcriptomic and metabolomic profiles with genome-wide association study (GWAS) data, to identify peripheral metabolites potentially linking early retinal lesions. Results: STZ-induced mice exhibited retinal inflammation and metabolic dysregulation. Metabolites including glucose, sorbitol, and mannitol were altered in both serum and retina, implicating their potential involvement in retinal inflammation. Utilizing GWAS data of diabetic patients, we further explore the potential the upstream regulation of shared metabolites and their peripheral pathways potentially instigating early retinal inflammation through metabolite-related genes correlated with single nucleotide polymorphisms. Key enzyme genes including HK1, HKDC1, AKR1B1 in hyperglycemic pathway, CEL and HMGCR in cholesterol pathway, and ACSL1, PPT2 in palmitic acid pathway, may connect the metabolic network of hyperglycemia, hyperfructosemia and disrupted lipid metabolism to retinopathy. Conclusion: This study elucidates the upstream regulatory network of peripheral serum metabolites associated with early retinal lesions. Specifically, the SNPs in key peripheral enzyme genes may exert remote effects on retinal inflammation in DR. This finding provides insights into the systemic metabolic management and offering peripheral precise early detection and treatment.http://www.sciencedirect.com/science/article/pii/S2405580825002699Diabetic retinopathyRetinaSerumMetabolomicsTranscriptomicsGWAS
spellingShingle Xiaonan Zhang
Yan Liu
Mengxue Xia
Manwen Yang
Yingjie Wu
Fang Zhang
Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy
Biochemistry and Biophysics Reports
Diabetic retinopathy
Retina
Serum
Metabolomics
Transcriptomics
GWAS
title Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy
title_full Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy
title_fullStr Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy
title_full_unstemmed Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy
title_short Multi-omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in STZ-induced early diabetic retinopathy
title_sort multi omics analysis of potential metabolic networks linking peripheral metabolic changes to inflammatory retinal conditions in stz induced early diabetic retinopathy
topic Diabetic retinopathy
Retina
Serum
Metabolomics
Transcriptomics
GWAS
url http://www.sciencedirect.com/science/article/pii/S2405580825002699
work_keys_str_mv AT xiaonanzhang multiomicsanalysisofpotentialmetabolicnetworkslinkingperipheralmetabolicchangestoinflammatoryretinalconditionsinstzinducedearlydiabeticretinopathy
AT yanliu multiomicsanalysisofpotentialmetabolicnetworkslinkingperipheralmetabolicchangestoinflammatoryretinalconditionsinstzinducedearlydiabeticretinopathy
AT mengxuexia multiomicsanalysisofpotentialmetabolicnetworkslinkingperipheralmetabolicchangestoinflammatoryretinalconditionsinstzinducedearlydiabeticretinopathy
AT manwenyang multiomicsanalysisofpotentialmetabolicnetworkslinkingperipheralmetabolicchangestoinflammatoryretinalconditionsinstzinducedearlydiabeticretinopathy
AT yingjiewu multiomicsanalysisofpotentialmetabolicnetworkslinkingperipheralmetabolicchangestoinflammatoryretinalconditionsinstzinducedearlydiabeticretinopathy
AT fangzhang multiomicsanalysisofpotentialmetabolicnetworkslinkingperipheralmetabolicchangestoinflammatoryretinalconditionsinstzinducedearlydiabeticretinopathy